AMAG Pharmaceuticals, Inc. (AMAG) Analysts See $-0.48 EPS; Bnp Paribas Arbitrage Sa Has Lifted By $31.36 Million Its Core Molding Technologies (CMT) Holding

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Logo

Bnp Paribas Arbitrage Sa increased Core Molding Technologies Inc (CMT) stake by 201.53% reported in 2017Q4 SEC filing. Bnp Paribas Arbitrage Sa acquired 1,445 shares as Core Molding Technologies Inc (CMT)’s stock declined 25.21%. The Bnp Paribas Arbitrage Sa holds 2,162 shares with $46.92M value, up from 717 last quarter. Core Molding Technologies Inc now has $126.89 million valuation. The stock decreased 3.99% or $0.67 during the last trading session, reaching $16.13. About 28,943 shares traded or 13.04% up from the average. Core Molding Technologies, Inc. (NYSEMKT:CMT) has risen 1.90% since April 30, 2017 and is uptrending. It has underperformed by 9.65% the S&P500.

Analysts expect AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) to report $-0.48 EPS on May, 1.They anticipate $0.58 EPS change or 54.72% from last quarter’s $-1.06 EPS. After having $0.10 EPS previously, AMAG Pharmaceuticals, Inc.’s analysts see -580.00% EPS growth. The stock increased 1.98% or $0.4 during the last trading session, reaching $20.65. About 605,546 shares traded. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has declined 16.25% since April 30, 2017 and is downtrending. It has underperformed by 27.80% the S&P500.

Investors sentiment decreased to 0.9 in Q4 2017. Its down 0.54, from 1.44 in 2017Q3. It dropped, as 29 investors sold AMAG Pharmaceuticals, Inc. shares while 53 reduced holdings. 24 funds opened positions while 50 raised stakes. 37.72 million shares or 5.64% less from 39.98 million shares in 2017Q3 were reported. 59,455 are owned by Arizona State Retirement System. The New York-based Morgan Stanley has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Globeflex Limited Partnership has 0.02% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Us Retail Bank De has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Geode Mngmt Ltd Liability Corp has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). 19,462 are owned by Royal Comml Bank Of Canada. Renaissance Tech Lc holds 851,900 shares. Massachusetts-based Acadian Asset Llc has invested 0.03% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Piermont Mngmt accumulated 13,110 shares or 0.06% of the stock. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,049 shares or 0% of its portfolio. Price T Rowe Md has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Group Inc One Trading Limited Partnership stated it has 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Massachusetts Fincl Ma reported 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Voya Invest Mgmt Limited Liability Corp owns 41,385 shares. Quantbot Technologies Limited Partnership, a New York-based fund reported 1,844 shares.

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, makes, develops, and commercializes therapeutics for women??s health, anemia management, and cancer supportive care in the United States. The company has market cap of $708.79 million. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme , an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. It currently has negative earnings. The firm also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units for pregnant women and their families.

Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. AMAG Pharmaceuticals has $89 highest and $15.0 lowest target. $27.92’s average target is 35.21% above currents $20.65 stock price. AMAG Pharmaceuticals had 46 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was maintained by Cantor Fitzgerald with “Hold” on Monday, June 26. The company was maintained on Thursday, February 15 by Jefferies. The rating was maintained by Cowen & Co on Tuesday, February 27 with “Hold”. Piper Jaffray maintained it with “Hold” rating and $15.0 target in Thursday, January 18 report. As per Wednesday, May 4, the company rating was downgraded by Raymond James. Janney Capital upgraded the shares of AMAG in report on Thursday, February 15 to “Buy” rating. Deutsche Bank maintained the shares of AMAG in report on Thursday, November 19 with “Hold” rating. On Thursday, November 2 the stock rating was maintained by Cantor Fitzgerald with “Hold”. The rating was downgraded by Leerink Swann to “Mkt Perform” on Tuesday, January 10. The company was maintained on Tuesday, June 6 by Jefferies.

Since February 23, 2018, it had 0 buys, and 1 insider sale for $16,016 activity. Another trade for 770 shares valued at $16,016 was made by Vittiglio Joseph on Friday, February 23.

Investors sentiment increased to 1.63 in Q4 2017. Its up 0.32, from 1.31 in 2017Q3. It improved, as 5 investors sold CMT shares while 19 reduced holdings. 14 funds opened positions while 25 raised stakes. 5.59 million shares or 0.09% less from 5.59 million shares in 2017Q3 were reported. Strs Ohio has invested 0% of its portfolio in Core Molding Technologies, Inc. (NYSEAMERICAN:CMT). Teton Advsrs stated it has 298,500 shares. Glenmede Na has invested 0% in Core Molding Technologies, Inc. (NYSEAMERICAN:CMT). 322,518 were accumulated by Vanguard Grp Incorporated. Schwab Charles Investment accumulated 12,400 shares. Barclays Public Limited reported 0% stake. Acadian Asset Limited Liability Company invested in 0.03% or 295,652 shares. James Invest Research Incorporated holds 0% or 2,629 shares in its portfolio. Parallax Volatility Advisers Limited Partnership stated it has 1,092 shares. Geode Mgmt Limited Liability Company holds 0% or 58,067 shares. State Bank Of America De holds 2,147 shares. Moreover, Gamco Et Al has 0.03% invested in Core Molding Technologies, Inc. (NYSEAMERICAN:CMT) for 243,700 shares. 658,280 are owned by Dimensional Fund Advsrs Limited Partnership. Hotchkis And Wiley Cap Lc owns 19,966 shares. Ajo LP invested 0% in Core Molding Technologies, Inc. (NYSEAMERICAN:CMT).

Core Molding Technologies, Inc. (NYSEAMERICAN:CMT) Institutional Positions Chart